PCV3 COMPARISON OF MORTALITY, HEALTH CARE UTILITY AND COST OF PATIENTS WITH WARFARIN TREATMENT FOR NON-VALVULAR ATRIAL FIBRILLATION VERSUS PATIENTS WITH OTHER TREATMENT
Abstract
Authors
L Wang O Baser
L Wang O Baser
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now